More Company News

MaxCyte

Editas clinical and commercial license agreement
07 Oct 2019Read More

MaxCyte

H119 results
18 Sep 2019Read More

MaxCyte

Trading update
17 Jul 2019Read More

MaxCyte

Capital Markets Day 2019
11 Jul 2019Read More

MaxCyte

CARMA Phase I trial progresses
08 May 2019Read More

MaxCyte

FY18 results
24 Apr 2019Read More

MaxCyte

Launch of ExPERT instrument family
08 Apr 2019Read More

MaxCyte

Clinical and commercial agreement with Kite
01 Mar 2019Read More

MaxCyte

Results of placing
05 Feb 2019Read More

MaxCyte

Proposed placing to raise a minimum of £10m
05 Feb 2019Read More

1 2 3 4 5
Return to MaxCyte
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).